Janne Pott

Dr. Janne Pott

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
NFNora Franceschini
Nora Franceschini
CGClaudia Giambartolomei
Claudia Giambartolomei
PVPaul S de Vries
Paul S de Vries
CFChris Finan
Chris Finan
JBJoshua C Bis
Joshua C Bis
COChristopher J O'Donnell
Christopher J O'Donnell
Carotid artery intima media thickness (cIMT) and carotid plaque are measures of subclinical atherosclerosis associated with ischemic stroke and coronary heart disease (CHD). Here, we undertake meta-analyses of genome-wide association studies (GWAS) in 71,128 individuals for cIMT, and 48,434 individuals for carotid plaque traits. We identify eight novel susceptibility loci for cIMT, one independent association at the previously-identified PINX1 locus, and one novel locus for carotid plaque. Colocalization analysis with nearby vascular expression quantitative loci (cis-eQTLs) derived from arterial wall and metabolic tissues obtained from patients with CHD identifies candidate genes at two potentially additional loci, ADAMTS9 and LOXL4. LD score regression reveals significant genetic correlations between cIMT and plaque traits, and both cIMT and plaque with CHD, any stroke subtype and ischemic stroke. Our study provides insights into genes and tissue-specific regulatory mechanisms linking atherosclerosis both to its functional genomic origins and its clinical consequences in humans.

6 June 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
JPJanne Pott
Janne Pott
YBYoon Ju Bae
Yoon Ju Bae
KHKatrin Horn
Katrin Horn
ATAndrej Teren
Andrej Teren
AKAndreas Kühnapfel
Andreas Kühnapfel
MSMarkus Scholz
Markus Scholz
Context Steroid hormones are important regulators of physiological processes in humans and are under genetic control. A link to coronary artery disease (CAD) is supposed. Objective Our main objective was to identify genetic loci influencing steroid hormone levels. As secondary aim, we searched for causal effects of steroid hormones on CAD. Design We conducted genome-wide meta-association studies for eight steroid hormones: cortisol, DHEA-S, estradiol and testosterone in two independent cohorts (LIFE-Adult, LIFE-Heart, max. n=7667), and progesterone, 17-hydroxyprogesterone, androstenedione and aldosterone in LIFE-Heart only (max. n=2070). All genome-wide significant loci were tested for sex interactions. Further, we tested if previously reported CAD SNPs were associated with our steroid hormone panel and investigated causal links between hormone levels and CAD status using Mendelian Randomization (MR) approaches. Results We discovered 15 novel associated loci for 17-hydroxyprogesterone, progesterone, DHEA-S, cortisol, androstenedione, and estradiol. Five of these loci relate to genes directly involved in steroid metabolism: CYP21A1, CYP11B1, CYP17A1, STS, and HSD17B12, almost completing the set of steroidogenic enzymes with genetic associations. Sexual dimorphisms were found for seven of the novel loci. Other loci correspond, e.g., to the WNT4/β-catenin pathway. MR revealed that cortisol, androstenedione, 17-hydroxyprogesterone and DHEA-S had causal effects on CAD. We also observed enrichment of cortisol and testosterone associations among known CAD hits. Conclusion Our study greatly improves insight into genetic regulation of steroid hormones and their dependency on sex. These results could serve as a basis for analyzing sex-dimorphisms in other complex diseases.

1 May 2018 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
JPJanne Pott
Janne Pott
VSValentin Schlegel
Valentin Schlegel
ATAndrej Teren
Andrej Teren
KHKatrin Horn
Katrin Horn
HKHolger Kirsten
Holger Kirsten
MSMarkus Scholz
Markus Scholz
Background: Inhibition of PCSK9 (proprotein convertase subtilisin/kexin type 9) is a novel strategy to treat hypercholesterolemia and reduce cardiovascular events. However, the potential role of circulating plasma PCSK9 concentrations as a diagnostic and predictive biomarker remains uncertain as of now. Here, we aimed to identify genetic variants associated with plasma PCSK9 and investigate possible causal effects on atherosclerotic vascular disease phenotypes. Methods: We performed the first genome-wide association study of plasma PCSK9 levels in a cohort of suspected and confirmed coronary artery disease (LIFE-Heart; n=3290). Results: Several independent variants at the PCSK9 gene locus were associated with circulating PCSK9 levels at genome-wide significance (lead SNP rs11591147, PCSK9-R46L; P =1.94×10 −17 ). We discovered 4 independent PCSK9 SNPs explaining 4.4% of the variance of plasma PCSK9. In addition, we identified a genome-wide significant locus at chromosome 7p22.1 (rs6957201; P =7.01×10 −9 ) and 7 suggestive hits ( P <1×10 −6 ). Using MR (Mendelian Randomization), we detected significant causal effects of circulating PCSK9 on coronary artery disease status and severity, carotid plaques, and intima-media thickness. Conclusions: Variants at the PCSK9 gene locus seem to be the major genetic determinants of plasma PCSK9 levels with 4 independent variants at the PCSK9 gene locus expressing allelic heterogeneity. The detected MR estimates support the hypothesis of a causal effect of PCSK9 on coronary artery disease and other vascular phenotypes. Other observed genetic associations for PCSK9 require validation in independent cohorts. Clinical Trial Registration: URL: http://www.clinicaltrials.gov . Unique Identifier: NCT00497887.

10 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMarkus Scholz
Markus Scholz
KHKatrin Horn
Katrin Horn
JPJanne Pott
Janne Pott
AGArnd Gross
Arnd Gross
MKMarcus E. Kleber
Marcus E. Kleber
UCUta Ceglarek
Uta Ceglarek
Phytosterol serum concentrations are under tight genetic control. The relationship between phytosterols and coronary artery disease (CAD) is controversially discussed. We perform a genome-wide meta-analysis of 32 phytosterol traits reflecting resorption, cholesterol synthesis and esterification in six studies with up to 9758 subjects and detect ten independent genome-wide significant SNPs at seven genomic loci. We confirm previously established associations at ABCG5/8 and ABO and demonstrate an extended locus heterogeneity at ABCG5/8 with different functional mechanisms. New loci comprise HMGCR, NPC1L1, PNLIPRP2, SCARB1 and APOE. Based on these results, we perform Mendelian Randomization analyses (MR) revealing a risk-increasing causal relationship of sitosterol serum concentrations and CAD, which is partly mediated by cholesterol. Here we report that phytosterols are polygenic traits. MR add evidence of both, direct and indirect causal effects of sitosterol on CAD.

1 April 2017 in Atherosclerosis
Verified
Journal Article
Closed access
JPJanne Pott
Janne Pott
RBRalph Burkhardt
Ralph Burkhardt
FBFrank Beutner
Frank Beutner
KHKatrin Horn
Katrin Horn
ATAndrej Teren
Andrej Teren
MSMarkus Scholz
Markus Scholz

3 August 2020 in International Journal of Epidemiology
Verified
Journal Article
Closed access
MSMarkus Scholz
Markus Scholz
SHSylvia Henger
Sylvia Henger
FBFrank Beutner
Frank Beutner
ATAndrej Teren
Andrej Teren
RBRonny Baber
Ronny Baber
JTJoachim Thiery
Joachim Thiery